Shopping Cart 0
Cart Subtotal
USD 0

Biogen Inc (BIIB) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Biogen Inc (Biogen) is a global biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases worldwide. The company's marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbryta (daclizumab), Fampyra (prolonged-release fampridine tablets) and Plegridy (peginterferon beta-1a) for the treatment of multiple sclerosis (MS); Spinraza (nusinersen) for spinal muscular atrophy (SMA); and Fumaderm (fumaric acid esters) for severe plaque psoriasis. The company also offers biosimilars through its joint venture, Samsung Bioepis. It has several products candidates targeting various indications such as MS, Parkinson's disease, Alzheimer's disease and idiopathic pulmonary fibrosis, stroke, among others. The company sells its products through direct sales forces, marketing groups and distributors in the Americas, Europe, Asia and other territories. Biogen is headquartered in Cambridge, Massachusetts, the US.

Biogen Inc (BIIB)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Biogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biogen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Biogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biogen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Biogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Biogen Inc, Medical Equipment, Deal Details 11

Partnerships 11

Biogen Expands Licensing Agreement with Absorption Systems 11

Siemens Healthcare Enters into Co-Development Agreement with Biogen 12

Enigma Biomedical Enters into Research Agreement with Biogen and Merck 13

AC Immune Enters into Partnership with Biogen 14

Oklahoma Medical Research Foundation Enters into Research Agreement with Biogen 15

Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 16

Regulus Therapeutics Amends Agreement With Biogen Idec 17

Regulus Therapeutics Terminates an Agreement With Biogen Idec For Biomarkers 18

Debt Offering 19

Biogen Raises USD1.75 Billion in Public Offering of 4.05% Notes Due 2025 19

Biogen Raises USD1 Billion in Public Offering of 3.625% Notes Due 2022 21

Biogen Raises USD1.5 Billion in Public Offering of 2.9% Notes Due 2020 23

Biogen Raises USD1.75 Billion in Public Offering of 5.2% Notes Due 2045 25

Acquisition 27

Bristol-Myers Rumored To Acquire Biogen Idec 27

Biogen Inc-Key Competitors 28

Biogen Inc-Key Employees 29

Biogen Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Joint Venture 35

Recent Developments 36

Strategy And Business Planning 36

Jun 21, 2018: MyHealthTeams Launches "MS & Cognition" Resource Center to Educate Multiple Sclerosis Patients about Brain Health 36

Financial Announcements 37

Jul 24, 2018: Biogen Q2 2018 revenues increase 9% tO USD 3.4 37

Jan 25, 2018: Biogen Reports Revenues for Both the Full Year and Fourth Quarter of 2017 40

Oct 24, 2017: Biogen Reports Quarterly Revenues of USD 3.1 Billion 43

Jul 25, 2017: Biogen Reports Record Quarterly Revenues of USD 3.1 Billion, Raises Full Year Revenue Guidance 45

Apr 25, 2017: Biogen Reports First Quarter 2017 Revenues of USD 2.8 Billion 48

Jan 26, 2017: Biogen Reports 2016 Revenues of USD 11.4 Billion 50

Corporate Communications 52

May 31, 2018: Biogen Appoints Daniel Karp as EVP Corporate Development 52

Dec 04, 2017: Biogen Appoints Mark Hernon as SVP, Chief Information Officer 53

Nov 21, 2017: Biogen Appoints Jeff Capello as Executive Vice President and Chief Financial Officer 54

Nov 02, 2017: Biogen Appoints Chirfi Guindo as Executive Vice President and Head of Global Marketing, Market Access and Customer Innovation 55

Sep 12, 2017: Biogen Appoints Sanjay Jariwala as SVP, Worldwide Medical 56

Jul 31, 2017: Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences 57

Jul 24, 2017: Alisha A. Alaimo Appointed SVP of Biogen's US Therapeutic Operations 58

Jul 10, 2017: Biogen Appoints Amy Chevalier Efantis Vice President of Government Affairs 59

Jun 28, 2017: Biogen Appoints Catherine Steele Senior Vice President of Corporate Affairs 60

Jun 20, 2017: Biogen Appoints Ginger Gregory Executive Vice President, Chief Human Resources Officer 61

Jun 14, 2017: Jean-Paul Kress Appointed EVP and President, International and Head of Global Therapeutic Operations 62

Jun 13, 2017: Biogen Announces Management Change 63

Mar 16, 2017: Biogen Appoints Anirvan Ghosh Senior Vice President, Research and Early Development 64

Legal and Regulatory 65

Sep 05, 2017: Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit 65

May 01, 2017: Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement 66

Feb 09, 2017: Forward Pharma Received USD 1.25bn pursuant to Settlement and License Agreement with Biogen 67

Jan 12, 2017: Biogen Spin-off Bioverativ Commences When-Issued Trading of Common Stock 68

Product News 69

Dec 21, 2017: Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit 69

Other Significant Developments 70

Jun 29, 2018: Biogen increases stake in Samsung Bioepis with USD 700m deal 70

Jun 14, 2017: Accenture Labs and 1QBit Work with Biogen to Apply Quantum Computing to Accelerate Drug Discovery 71

Appendix 72

Methodology 72

About GlobalData 72

Contact Us 72

Disclaimer 72


List Of Figure

List of Figures

Biogen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Biogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Biogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Biogen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Biogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biogen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Biogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biogen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Biogen Inc, Medical Equipment, Key Facts, 2017 2

Biogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Biogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Biogen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Biogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Biogen Inc, Deals By Market, 2012 to YTD 2018 9

Biogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Biogen Expands Licensing Agreement with Absorption Systems 11

Siemens Healthcare Enters into Co-Development Agreement with Biogen 12

Enigma Biomedical Enters into Research Agreement with Biogen and Merck 13

AC Immune Enters into Partnership with Biogen 14

Oklahoma Medical Research Foundation Enters into Research Agreement with Biogen 15

Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 16

Regulus Therapeutics Amends Agreement With Biogen Idec 17

Regulus Therapeutics Terminates an Agreement With Biogen Idec For Biomarkers 18

Biogen Raises USD1.75 Billion in Public Offering of 4.05% Notes Due 2025 19

Biogen Raises USD1 Billion in Public Offering of 3.625% Notes Due 2022 21

Biogen Raises USD1.5 Billion in Public Offering of 2.9% Notes Due 2020 23

Biogen Raises USD1.75 Billion in Public Offering of 5.2% Notes Due 2045 25

Bristol-Myers Rumored To Acquire Biogen Idec 27

Biogen Inc, Key Competitors 28

Biogen Inc, Key Employees 29

Biogen Inc, Other Locations 31

Biogen Inc, Subsidiaries 31

Biogen Inc, Joint Venture 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Biogen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.